Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer: What is Their Role?

Author： Tang Patricia A. Moore Malcolm J.

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.5, Iss.4, 2006-01, pp. : 213-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer

By Papageorgio Chris Perry Michael

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 647-657

Informa Healthcare

Access to resources Recommend Favorite

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

By Arnoletti J. Frolov A. Eloubeidi M. Keene K. Posey J. Wood T. Greeno Edward Jhala N. Varadarajulu S. Russo S. Christein J. Oster R. Buchsbaum D. Vickers S.

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite

Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

By Waksal H.W.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite

Serum and Correspondent Tissue Measurements of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGF-R): Clinical Relevance in Pancreatic Cancer and Chronic Pancreatitis

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 2, 1999-04 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in cancer treatment

By Ciardiello Fortunato

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 221-234

Future Medicine

Access to resources Recommend Favorite